Table 1.
Description of attributes and their levels
| Attribute | Level | Label | Description |
|---|---|---|---|
| 1. Trial duration | 1 | Short | 6‐9 months |
| 2 | Long | 15 to 18 months | |
| 2. Consultation frequency | 1 | Weekly | Weekly |
| 2 | Monthly | Monthly | |
| 3. Moderate SE (1% to 10%, few days) | 1 | Low | Digestive disorders (nausea, vomiting) |
| 2 | Intermediate | Flu‐type syndrome (fever, shivers, stiffness, joint pain) | |
| 3 | High | Digestive disorders, flu‐type syndrome, fatigue | |
| 4. Severe SE (<1/1000) | 1 | Low | Allergy |
| 2 | Intermediate | Allergy, infections | |
| 3 | High | Allergy, infections, risk of cancer a few years later (missing data for estimating how frequent the risk is) | |
| 5. Outcomes (ATI duration, % of success) | 1 | 3 to 6 months, 5% | ATI of three to six months, for 5% of patients |
| 2 | 6 to 12 months, 10% | ATI of six to twelve months, for 10% of patients |
SE, side effects.